Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Kogenate FS (BAY14-2222)
Also known as: Kogenate, antihemophilic factor
print preview
bookmark
share with colleague
General Information
Company
Bayer AG
Description
Recombinant Factor VIII (rFVIII) formulated with sucrose
Molecular Target
Factor VIII
Mechanism of Action
Procoagulant
Latest Stage of Development
Marketed
Indication
Hemophilia
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy